SYNAGISTICS (02562) releases the performance for the year 2025, with a net loss attributable to shareholders of 51.49 million Singapore dollars, a decrease of 80.9% compared to the previous year.
Lion-Tiger Holdings (02562) released its annual performance as at December 31, 2025, with a revenue of 83.874 million Singapore dollars, a year-on-year decrease of 17.7%; the company's attributable loss was 51.49 million Singapore dollars, a year-on-year reduction of 80.9%; basic loss per share was 11.53 Singapore cents.
Synagistics (02562) announced its annual performance as of December 31, 2025, with revenue of 83.874 million Singapore dollars, a year-on-year decrease of 17.7%; the company's attributable loss was 51.49 million Singapore dollars, a year-on-year decrease of 80.9%; basic loss per share was 11.53 Singapore cents.
The decrease in total revenue during the period was mainly due to the Group's continued acceleration towards a higher-profit D2B business model, strategically reducing the lower-profit D2C revenue.
Related Articles

FW FASHION INT (02528) releases annual performance, with a net profit attributable to shareholders of HK$ 57.673 million, turning losses into profits on a year-on-year basis.

INGDAN (00400) announced its performance for 2025, with a net profit attributable to shareholders of approximately 215 million yuan, an increase of 13.1% year-on-year.

MEDSCI (02415) released its annual performance, with a net profit attributable to shareholders of 1793.7 million yuan, a decrease of 28.16% compared to the previous year.
FW FASHION INT (02528) releases annual performance, with a net profit attributable to shareholders of HK$ 57.673 million, turning losses into profits on a year-on-year basis.

INGDAN (00400) announced its performance for 2025, with a net profit attributable to shareholders of approximately 215 million yuan, an increase of 13.1% year-on-year.

MEDSCI (02415) released its annual performance, with a net profit attributable to shareholders of 1793.7 million yuan, a decrease of 28.16% compared to the previous year.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


